Holen Sie sich die Stockscreener-App
0.388
0.26%
-0.001
Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Selling, General, and Administrative
|
53.53%
4.219
|
2.748 | 1.15 | 0.833 | 2.297 |
| Operating Income/Loss |
65.43%
-5.595
|
-3.382 | -1.513 | -1.932 | -3.604 |
| Nonoperating Income/Loss |
100.97%
-0.113
|
11.68 | -28.66 | 1.156 | 0.193 |
| Income/Loss From Continuing Operations Before Tax |
168.78%
-5.708
|
8.299 | -30.17 | -0.80 | -3.411 |
| Income/Loss From Continuing Operations After Tax |
168.78%
-5.708
|
8.299 | -30.17 | -0.80 | -3.411 |
|
Net Income/Loss
|
168.78%
-5.708
|
8.299 | -30.17 | -0.80 | -3.411 |
| Preferred Stock Dividends And Other Adjustments |
56.97%
1.808
|
4.202 | 0.085 | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | -0.024 | - |
| Basic Average Shares |
36.86%
2.4882
|
3.9407 | 2.7718 | 2.3451 | 2.2343 |
| Diluted Average Shares |
36.86%
2.4882
|
3.9407 | 2.7718 | 2.3451 | 2.2343 |
| Basic Earnings Per Share |
113.46%
2.22
|
1.04 | -10.92 | -0.33 | -1.53 |
| Diluted Earnings Per Share |
113.46%
2.22
|
1.04 | -10.92 | -0.33 | -1.53 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
56.97%
1.808
|
4.202 | 0.085 | - | - |
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):